Health News Archive - May 06, 2009
NANJING, China, May 6 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals in China, announced today that it intends to release its 2009 first quarter results on Monday, May 18, 2009, after the market closes in the United States.
Exercise, which plays an important role in both primary and secondary prevention of cancer, may be beneficial to lung cancer patients, U.S. researchers say. Dr.
CAPE TOWN, South Africa, May 6 /PRNewswire/ -- The healthcare industry in South Africa faces substantial challenges, including vast inequalities in access to care.
Broadest Extension of M. D. Anderson Clinical Services Outside of Houston PHOENIX, May 6 /PRNewswire/ -- Today Banner Health and The University of Texas M. D. Anderson Cancer Center announced they will create the M. D. Anderson Banner Cancer Center here.
TEL AVIV, Israel, May 6 /PRNewswire/ -- InspireMD, developers of MGuard(TM), announced today that the first patient has been enrolled in the iMOS registry. MGuard(TM) was successfully implanted at the General University Hospital in Prague; the procedure was performed by Dr.
NANJING, China, May 6 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals in China, announced today that the Company is seeking approval to manufacture and sell products containing zanamivir, one of only two WHO approved drugs to which the new H1N1 strain of influenza A has been shown to be susceptible. GlaxoSmithKline granted a license to Simcere in 2006 to make products containing zanamivir.
HOUSTON, May 6 /PRNewswire-FirstCall/ -- Carriage Services, Inc. (NYSE: CSV) today announced that it will participate in the Bank of America and Merrill Lynch 2009 Health Care Conference to be held May 12-14, 2009 at The Palace Hotel in New York City.
SAN DIEGO, May 6 /PRNewswire-FirstCall/ -- AMN Healthcare Services, Inc. (NYSE: AHS), the nation's largest healthcare staffing company, is scheduled to make a presentation on Tuesday, May 12, 2009 at 2:40 p.m.
RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE: GSK) today announced that it has entered into an agreement to divest full commercial rights to Wellbutrin XL(R) in the United States to Biovail International Laboratories SRL, a subsidiary of Biovail Corporation (NYSE, TSX: BVF), for $510 million (euro 340 million).
SANTA CLARA, Calif., May 6 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN) announced today that executives of Align Technology, are scheduled to speak at two upcoming financial conferences.